Intervention to reduce unnecessary dispensing of short-acting β-agonists in patients with asthma

Annals of Pharmacotherapy

Volumn 44, Issue 4, 2010, Pages 623-629

  Wong, Mark D ^a   Manley, R Thomas ^b   Stettin, Glen ^b   Chen, William ^b   Salmun, Luis M ^b  

^a Medco Health Solutions Inc   (United States)

^b Medco Health Solutions   (United States)

Author keywords

agonist use; Asthma; Intervention; Pharmacy

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ADULT; ARTICLE; ASTHMA; CLINICAL ASSESSMENT; CLINICAL PHARMACY; CONTROLLED STUDY; DISEASE CONTROL; DRUG USE; EMERGENCY WARD; FEMALE; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; INCIDENCE; INTERVENTION STUDY; MALE; METERED DOSE INHALER; OUTCOME ASSESSMENT; POPULATION; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ADULT; AGED; ASTHMA; COHORT STUDIES; COST SAVINGS; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHARMACISTS; RETROSPECTIVE STUDIES;

EID: 77950608740     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M697     Document Type: Article

References (29)

1. Expert Panel Report III: guidelines for diagnosis and management of asthma - summary report. Bethesda MD: National Heart, Lung, and Blood Institute. J Allergy Clin Immunol 2007;120:S94-138. DOI 10.1016/j.jaci.2007.09.029
2. Cockcroft D, McParland C, Britto S, et al. Regular inhaled salbutamol and airway hyperresponsiveness to allergen. Lancet 1993;342:833-837 (Pubitemid 23285911)
3. Vathenen A, Knox A, Higgins B, et al. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1988;1:554-558 DOI 10.1016/S0140-6736(88)91352-9 (Pubitemid 18060479)
4. Cockcroft D, O'Byrne P, Swystun V, et al. Regular use of inhaled albuterol and the allergen-induced late asthmatic response. J Allergy Clin Immunol 1995;96:44-49 DOI 10.1016/S0091-6749(95)70031-5
5. Cockcroft D, Swystun V, Bhagat R. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine. Am J Respir Crit Care Med 1995;152:1485-1489
6. Bhagat R, Swystun V, Cockcroft D. Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response. J Allergy Clin Immunol 1996;97:47-52. DOI 10.1016/S0091-6749(96)70282- 8 (Pubitemid 26045968)
7. Package insert. Ventolin HFA oral inhalation aerosol (albuterol sulfate HFA oral inhalation aerosol). Research Triangle Park, NC: Glaxo-SmithKline, June 2004.
8. Kung M, Croley S, Phillips B. Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol: influence of mouth rinsing and gargling. Chest 1987;91:382-387 DOI 10.1378/chest.91.3.382 (Pubitemid 17027617)
9. Suissa S, Ernst P, Boivin J, et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 1994;149:604-610 (Pubitemid 24082213)
10. Sears M. Deleterious effects of inhaled beta agonists: short-acting and long-acting agents differ. Chest 2001;119:1297-1299 (Pubitemid 32686005)
11. Aslam A, Lynd L, Wang X, et al. Double trouble: impact of inappropriate use of asthma medication on the use of healthcare resources. CMAJ 2001;164:625-631 (Pubitemid 32193861)
12. Taylor D, Sears M, Herbison G, et al. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function. Thorax 1993;48: 134-138 DOI 10.1136/thx.48.2.134 (Pubitemid 23057218)
13. van Schayck G, Dompeling E, van Herwaarden C, et al. Long-term effects of continuous versus symptomatic bronchodilator treatment in patients with moderate asthma or chronic bronchitis. BMJ 1991;303:1426-1431
14. Paris J, Peterson E, Wells K, et al. Relationship between recent short-acting beta agonist use and subsequent asthma exacerbations. Ann Allergy Asthma Immunol 2008;101:482-487
15. Hong S, Sanders B, West D. Inappropriate use of inhaled short acting beta-agonists and its association with patient health status. Curr Med Res Opin 2006; 22:33-40. DOI 10.1185/030079905X74934 (Pubitemid 43106905)
16. Shireman TI, Heaton PC, Gay WE, Cluxton RJ, Moomaw CJ. Relationship between asthma drug therapy patterns and healthcare utilization. Ann Pharmacother 2002;36:557-564 DOI 10.1345/aph.1A067 (Pubitemid 34270265)
17. Blais R, Laurier C, Paré M. Effect of feedback letters to physicians and pharmacists on the appropriate use of medication in the treatment of asthma. J Asthma 2008;45:227-231 DOI 10.1080/02770900701883774 (Pubitemid 351549803)
18. Lee E, McNally DL, Zuckerman IH. Evaluation of a physician-focused educational intervention on Medicaid children with asthma. Ann Pharmacother 2004;38:961-966 DOI 10.1345/aph.1D515 (Pubitemid 38657734)
19. Coleman CI, Reddy P, Laster-Bradley NM, Dorval S, Munagala B, White CM. Effect of practitioner education on adherence to asthma treatment guidelines. Ann Pharmacother 2003;37:956-961 DOI 10.1345/aph.1C506 (Pubitemid 36875221)
20. Kattan M, Crain E, Steinbach S, et al. A randomized clinical trial of clinician feedback to improve quality of care for inner-city children with asthma. Pediatrics 2006;117:1095-1103 DOI 10.1542/peds.2005-2160 (Pubitemid 46071204)
21. Sondergaard J, Andersen M, Vach K, et al. Detailed postal feedback about prescribing to asthma patients combined with a guideline statement showed non impact: a randomized controlled trial. Eur J Clin Pharmacol 2002;58:127-132 (Pubitemid 34507796)
22. Duncan JC, Rogers R. Medication compliance in patients with chronic schizophrenia: implications for the community management of mentally disordered offenders. J Forensic Sci 1998;43:1133-1137 DOI 10.1016/S1353-1131(99)90221-3 (Pubitemid 28554808)
23. Gary TL, Crum RM, Cooper-Patrick L, Ford D, Brancati FL. Depressive symptoms and metabolic control in African Americans with type 2 diabetes. Diabetes Care 2000;23:23-29 DOI 10.2337/diacare.23.1.23 (Pubitemid 30022889)
24. Skaer TL, Sclar DA, Markowski DJ, Won JK. Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures: a study of patients with non-insulin-dependent diabetes mellitus. J Clin Pharm Ther 1993;18:295-299 Doi 10.1111/j.1365-2710.1993.tb00591.x
25. Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004;114:1288-1293 DOI 10.1016/j.jaci.2004.09.028 (Pubitemid 39575880)
26. Senthiselvan A, Lawson J, Rennie D, et al. Regular use of corticosteroids and low use of short-acting beta-2 agonists can reduce asthma hospital-ization. Chest 2005;127:1242-1251 (Pubitemid 46224287)
27. Krishnan JA, Riekert KA, McCoy JV, et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med 2004;170:1281-1285 DOI 10.1164/rccm.200403-409OC (Pubitemid 39657191)
28. Food and Drug Administration, HHS. Use of ozone-depleting substances; removal of essential-use designations. Final rule. Fed Regist 2005;70:17167-17192
29. Brook RH. Disruption and innovation in health care. JAMA 2009;302: 1465-1466 DOI 10.1001/jama.2009.1427